Business ❯Pharmaceutical Industry ❯Drug Development ❯Novo Nordisk

Ozempic

Dow Hits Record High Amid Strong US Jobs Report and Middle East Tensions

Novo Nordisk's Amycretin Pill Shows Promising Weight Loss Results in Early Trial